z-logo
open-access-imgOpen Access
Plasmapheresis as treatment for patients with severe hypertriglyceridemia
Author(s) -
Okan Bakıner
Publication year - 2020
Publication title -
medicine science | international medical journal
Language(s) - English
Resource type - Journals
ISSN - 2147-0634
DOI - 10.5455/medscience.2020.09.9183
Subject(s) - plasmapheresis , hypertriglyceridemia , acute pancreatitis , medicine , pancreatitis , triglyceride , extracorporeal , hyperlipidemia , intensive care medicine , gastroenterology , diabetes mellitus , endocrinology , cholesterol , immunology , antibody
Severe hypertriglyceridemia (SHGT) occurs when triglyceride values exceed 1,000 mg/dl which places patients at considerable risk of acute pancreatitis. Treatment of SHGT includes lipid lowering approches and dietary interventions. Insulin infusion is considered to decrease triglyceride levels in patients who display SHTG related acute pancreatitis. Plasmapheresis is an effective method and an extracorporeal process which may be used both in urgent and in selective cases. Plasma exchange and double cascade filtration are methods of plasmapheresis used in SHTG and possible following acute pancreatitis. In this article effect and mechanisms of plasmapheresis on SHTG and related acute pancreatitis will be discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom